🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

225 results for “Shanghai” Clear

  1. SSS06

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chemotherapy-induced Anemia

    phase 2 small molecule active

    1 trial

  2. SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Anemia in Pre-Dialysis Patients

    phase 2 small molecule completed

    1 trial

  3. SSS17 Capsule (6 Dose Levels)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Postoperative Anemia

    phase 2 small molecule active

    1 trial

  4. TQC2731 injection

    Shanghai University of Traditional Chinese Medicine

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule active

    1 trial

  5. TQH2722 injection

    Shanghai University of Traditional Chinese Medicine

    Seasonal Allergic Rhinitis

    phase 2 small molecule active

    1 trial

  6. Z650

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  7. cis Platinum/Carboplatin, Pemetrexed Disodium

    Shanghai University of Traditional Chinese Medicine

    Chemotherapy, Adjuvant

    phase 2 small molecule active

    1 trial

  8. neoadjuvant anti-PD-1

    Shanghai Chest Hospital

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  9. two-drug chemotherapy containing platinum, including carboplatin/Cisplatin + pemetrexed/docetaxel/paclitaxel/etoposide/gemcitabine/vinorelbine/albumin-bound paclitaxel

    Shanghai Chest Hospital

    NSCLC

    phase 2 small molecule active

    1 trial

  10. 14028 injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 mab completed

    1 trial

  11. 304 injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    CD20 Positive B Cell NHL

    phase 1 small molecule active

    1 trial

  12. 608

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Moderate to Severe Plaque Psoriasis

    phase 1 small molecule active

    1 trial

  13. 609A

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Solid Tumors

    phase 1 small molecule active

    2 trials

  14. 610

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma

    phase 1 small molecule active

    1 trial

  15. 610 30mg group

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Asthma

    phase 1 small molecule active

    1 trial

  16. 626

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  17. 627

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 mab active

    1 trial

  18. 9MW3811 injection

    Shanghai University of Traditional Chinese Medicine

    Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  19. ATG-010 and ATG-008

    Shanghai Antengene Corporation Limited

    Relapsed/Refractory Diffuse Large B-cell Lymphoma

    phase 1 other terminated

    1 trial

  20. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  21. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule terminated

    1 trial

  22. Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)

    Shanghai Reinovax Biologics Co.,LTD

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  23. Clascoterone Cream 1%

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acne Vulgaris

    phase 1 small molecule completed

    1 trial

  24. Clifutinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Subject

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources